These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25970361)
1. Secondary osteosarcoma: is there a predilection for the chondroblastic subtype? Barker JP; Monument MJ; Jones KB; Putnam AR; Randall RL Orthopedics; 2015 May; 38(5):e359-66. PubMed ID: 25970361 [TBL] [Abstract][Full Text] [Related]
2. Chondroblastic osteosarcoma: Cytomorphologic characteristics and differential diagnosis on FNA. VandenBussche CJ; Sathiyamoorthy S; Wakely PE; Ali SZ Cancer Cytopathol; 2016 Jul; 124(7):493-500. PubMed ID: 26999748 [TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma of the flat bone. Lee JA; Kim MS; Koh JS; Kim MS; Kim DH; Lim JS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG Jpn J Clin Oncol; 2010 Jan; 40(1):47-53. PubMed ID: 19892781 [TBL] [Abstract][Full Text] [Related]
4. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma. Hauben EI; Arends J; Vandenbroucke JP; van Asperen CJ; Van Marck E; Hogendoorn PC Eur J Hum Genet; 2003 Aug; 11(8):611-8. PubMed ID: 12891382 [TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma as a second malignant neoplasm. Hamre MR; Severson RK; Chuba P; Lucas DR; Thomas RL; Mott MP Radiother Oncol; 2002 Dec; 65(3):153-7. PubMed ID: 12464443 [TBL] [Abstract][Full Text] [Related]
6. Her-2/neu, p-53, and their coexpression in osteosarcoma. Bakhshi S; Gupta A; Sharma MC; Khan SA; Rastogi S J Pediatr Hematol Oncol; 2009 Apr; 31(4):245-51. PubMed ID: 19346874 [TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma of the skin. Larsen S; Davis DM; Comfere NI; Folpe AL; Sciallis GF Int J Dermatol; 2010 May; 49(5):532-40. PubMed ID: 20534087 [TBL] [Abstract][Full Text] [Related]
8. Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Geirnaerdt MJ; Bloem JL; van der Woude HJ; Taminiau AH; Nooy MA; Hogendoorn PC Skeletal Radiol; 1998 Mar; 27(3):145-53. PubMed ID: 9554005 [TBL] [Abstract][Full Text] [Related]
9. Chondroblastic osteosarcoma of the cuboid: a literature review and report of a rare case. Fox C; Husain ZS; Shah MB; Lucas DR; Saleh HA J Foot Ankle Surg; 2009; 48(3):388-93. PubMed ID: 19423044 [TBL] [Abstract][Full Text] [Related]
10. Chondroblastic osteosarcoma of the distal tibia: a rare case report. Fredj AB; Hassini L; Fekih A; Allagui M; Aloui I; Abid A Pan Afr Med J; 2017; 27():11. PubMed ID: 28748013 [TBL] [Abstract][Full Text] [Related]
11. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827 [TBL] [Abstract][Full Text] [Related]
12. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype. Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501 [TBL] [Abstract][Full Text] [Related]
13. USCAP Specialty Conference, case 2: chondroblastic osteosarcoma with features resembling chondromyxoid fibroma. Hicks J Pediatr Dev Pathol; 2005; 8(1):67-73. PubMed ID: 15702366 [No Abstract] [Full Text] [Related]
14. Primary chondroblastic osteosarcoma of the breast. El Ochi MR; Zouaidia F; Kabaj R; El Ouazzanni H; Allaoui M; Oukabli M; Al Bouzidi A; El Khannoussi B Turk Patoloji Derg; 2014; 30(3):225-7. PubMed ID: 26033758 [TBL] [Abstract][Full Text] [Related]
15. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. Radig K; Häckel C; Herting J; Oda Y; Mittler U; Neumann W; Roessner A Gen Diagn Pathol; 1997 Feb; 142(3-4):139-45. PubMed ID: 9065577 [TBL] [Abstract][Full Text] [Related]
16. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer. Okada K; Hasegawa T; Yokoyama R; Beppu Y; Itoi E J Clin Pathol; 2003 Oct; 56(10):742-6. PubMed ID: 14514776 [TBL] [Abstract][Full Text] [Related]
17. The submicroscopic structure of a chondroblastic osteogenic sarcoma. Horn V; Spohrová D; Bozdĕch Z; Janecek M; Roessner A; Bucek J Arch Orthop Trauma Surg (1978); 1984; 103(2):100-6. PubMed ID: 6591867 [TBL] [Abstract][Full Text] [Related]
18. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan. Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085 [TBL] [Abstract][Full Text] [Related]
19. Chondroblastic osteosarcoma of the temporal region: a diagnostic dilemma. Gupta N; Rajwanshi A; Gupta P; Vaiphei K; Gupta AK Diagn Cytopathol; 2011 May; 39(5):377-9. PubMed ID: 20730902 [TBL] [Abstract][Full Text] [Related]
20. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]